Effect of sodium-glucose cotransporter-2 inhibitors on patients with essential hypertension and pre-hypertension: a meta-analysis

BACKGROUND: Sodium-glucose cotransporter-2 (SGLT2) inhibitors are novel, hypoglycemic drugs exhibiting cardiovascular protective activities. If SGLT2 inhibitors can be successfully used as antihypertensive drugs, they can be administered to patients with both hypertension and type 2 diabetes, thus d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Bangjiaxin, Chen, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747874/
https://www.ncbi.nlm.nih.gov/pubmed/36533186
http://dx.doi.org/10.1177/20420188221142450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747874/
https://www.ncbi.nlm.nih.gov/pubmed/36533186
http://dx.doi.org/10.1177/20420188221142450

Ejemplares similares